1,023 results on '"Nielsen, Ulrik"'
Search Results
52. Weighted single-step genomic best linear unbiased prediction integrating variants selected from sequencing data by association and bioinformatics analyses
53. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
54. Supplementary Table 4 from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
55. Supplementary Materials and Methods from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
56. Supplementary Tables S5, S6, S7, S8 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
57. Supplementary Figures 1-4, Table 1 from Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
58. Supplemental Figure 3 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
59. Supplementary Figure Legends from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
60. Data from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
61. Data from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
62. Supplementary Table S1 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
63. Supplemental table 1 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
64. Supplemental Figure 1 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
65. Supplementary Figures S1-S6 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
66. Supplemental table 2 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
67. Supplementary Figure Legend from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
68. Supplementary Table 3 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
69. Supplementary Tables S2, S3, S4 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
70. Supplemental Figure 2 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
71. Supplementary Figure 1 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
72. Supplementary Figures 1 through 10 and Supplementary Tables 1 through 3 from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
73. Supplementary Tables S1-S3 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
74. Supplementary Methods, Figures S1-S11, and Table Legends from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
75. Supplementary Materials and Methods from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
76. Supplemental figure legends from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
77. Supplementary Figure 2 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
78. Supplementary Table 2 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
79. Supplementary Table 1 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
80. Data from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
81. Supplemental Figure 4 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
82. Data from Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
83. Data from An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
84. Supplementary Methods, Figures 1-8, Table 1 from An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
85. Supplemental Methods from Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion
86. Supplemental Figures S1-S5, Tables S1-S2 from Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion
87. Estimating waves via measured ship responses
88. Hull and Propeller Performance Decomposition via an Adaptive Machine Learning Framework
89. Nielsen, Ulrik
90. Genetic Variation among Somatic Embryo Clones of Nordmann Fir Grown as Christmas Trees
91. Genetic Variation among Somatic Embryo Clones of Nordmann Fir Grown as Christmas Trees
92. Onboard Identification of Nonlinear Roll Damping Using Measured Ship Responses
93. Across-country test-day model evaluations for Holstein, Nordic Red Cattle, and Jersey
94. Deriving spatial wave data from a network of buoys and ships
95. Fairness is intuitive
96. Accumulated effects of factors determining plant development from somatic embryos of Abies nordmanniana and Abies bornmuelleriana
97. Production potential of 36 poplar clones grown at medium length rotation in Denmark
98. Ad hoc breeding of Abies bornmülleriana for Christmas tree production using a combination of DNA markers and quantitative genetics—a case study
99. Comparison of Methods for Estimation of On-site Directional Wave Spectra
100. Towards the uncertainty quantification of semi-empirical formulas applied to the added resistance of ships in waves of arbitrary heading
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.